Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule
- RxCUI
- 1723478
- RxNorm name
- Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule
- Display name
- Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule
- Full name
- Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pradaxa | DABIGATRAN ETEXILATE MESYLATE | Boehringer Ingelheim Pharmaceuticals Inc. | ba74e3cd-b06f-4145-b284-5fd6b84ff3c9 | 2025-06-25 | Boxed warning, Warnings, Adverse reactions | 1723478 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ba74e3cd-b06f-4145-b284-5fd6b84ff3c9 | Pradaxa 110 MG Oral Capsule [PSN] · dabigatran etexilate 110 MG Oral Capsule [Pradaxa] [SBD] · Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule [SY] · Pradaxa 110 MG Oral Capsule [SY] | 4 | 48 | These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA ® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 2010 | 20250625 |